BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38149470)

  • 21. Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD.
    Di Mauro S; Salomone F; Scamporrino A; Filippello A; Morisco F; Guido M; Lembo V; Cossiga V; Pipitone RM; Grimaudo S; Malaguarnera R; Purrello F; Piro S
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
    Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
    Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Protective Effects of Cinnamyl Alcohol Against Hepatic Steatosis, Oxidative and Inflammatory Stress in Nonalcoholic Fatty Liver Disease Induced by Childhood Obesity.
    Dai Y; Zhang X; Xu Y; Wu Y; Yang L
    Immunol Invest; 2023 Nov; 52(8):1008-1022. PubMed ID: 37962037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
    Yao Y
    Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
    Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice.
    Xia Y; Andersson E; Caputo M; Cansby E; Sedda F; Font-Gironès F; Ruud J; Kurhe Y; Hallberg B; Marschall HU; Asterholm IW; Romeo S; Blüher M; Mahlapuu M
    Mol Med; 2023 Oct; 29(1):138. PubMed ID: 37864157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease.
    Zhu T; Huang X; Zhu H; Chen J; Yao H; Zhang Y; Hua H; Zhang J; Qi J
    Phytomedicine; 2024 Jan; 123():155173. PubMed ID: 37976695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
    Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model.
    Zhu CG; Liu YX; Wang H; Wang BP; Qu HQ; Wang BL; Zhu M
    Endocr J; 2017 Jul; 64(7):663-673. PubMed ID: 28539530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
    Lai YS; Lee WC; Lin YE; Ho CT; Lu KH; Lin SH; Panyod S; Chu YL; Sheen LY
    J Agric Food Chem; 2016 Mar; 64(10):2062-71. PubMed ID: 26900108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of alkaloid extract from Codonopsis Radix in alleviating hepatic lipid accumulation: insights into mitochondrial energy metabolism and endoplasmic reticulum stress regulation in NAFLD mice.
    Fan C; Wang G; Chen M; Li Y; Tang X; Dai Y
    Chin J Nat Med; 2023 Jun; 21(6):411-422. PubMed ID: 37407172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression.
    Iannone V; Lok J; Babu AF; Gómez-Gallego C; Willman RM; Koistinen VM; Klåvus A; Kettunen MI; Kårlund A; Schwab U; Hanhineva K; Kolehmainen M; El-Nezami H
    J Nutr Biochem; 2023 May; 115():109307. PubMed ID: 36868506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E4orf1 Prevents Progression of Fatty Liver Disease in Mice on High Fat Diet.
    Afruza R; Dhurandhar NV; Hegde V
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease.
    Chikamatsu M; Watanabe H; Shintani Y; Murata R; Miyahisa M; Nishinoiri A; Imafuku T; Takano M; Arimura N; Yamada K; Kamimura M; Mukai B; Satoh T; Maeda H; Maruyama T
    J Control Release; 2023 Mar; 355():42-53. PubMed ID: 36690035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling.
    Hasan MK; Friedman TC; Sims C; Lee DL; Espinoza-Derout J; Ume A; Chalfant V; Lee ML; Sinha-Hikim I; Lutfy K; Liu Y; Mahata SK; Sinha-Hikim AP
    Endocrinology; 2018 Feb; 159(2):931-944. PubMed ID: 29272360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.